These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21561882)

  • 1. Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations.
    Singh AK; Tiwari MN; Dixit A; Upadhyay G; Patel DK; Singh D; Prakash O; Singh MP
    Toxicol Sci; 2011 Aug; 122(2):526-38. PubMed ID: 21561882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study.
    Agrawal S; Singh A; Tripathi P; Mishra M; Singh PK; Singh MP
    Mol Neurobiol; 2015 Apr; 51(2):448-65. PubMed ID: 24760363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration.
    Singh A; Tripathi P; Prakash O; Singh MP
    Mol Neurobiol; 2016 Dec; 53(10):6849-6858. PubMed ID: 26660326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood.
    Singh AK; Tiwari MN; Upadhyay G; Patel DK; Singh D; Prakash O; Singh MP
    Neurobiol Aging; 2012 Feb; 33(2):404-15. PubMed ID: 20371137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
    Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
    Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism.
    Zhao F; Cai T; Liu M; Zheng G; Luo W; Chen J
    Toxicol Sci; 2009 Jan; 107(1):156-64. PubMed ID: 18836210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys.
    Hurley SD; O'Banion MK; Song DD; Arana FS; Olschowka JA; Haber SN
    Exp Neurol; 2003 Dec; 184(2):659-68. PubMed ID: 14769357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.
    Kumar A; Singh BK; Ahmad I; Shukla S; Patel DK; Srivastava G; Kumar V; Pandey HP; Singh C
    Brain Res; 2012 Feb; 1438():48-64. PubMed ID: 22244881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.
    Gaugler MN; Genc O; Bobela W; Mohanna S; Ardah MT; El-Agnaf OM; Cantoni M; Bensadoun JC; Schneggenburger R; Knott GW; Aebischer P; Schneider BL
    Acta Neuropathol; 2012 May; 123(5):653-69. PubMed ID: 22361813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
    Bowyer JF; Robinson B; Ali S; Schmued LC
    Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system.
    Tiwari MN; Singh AK; Ahmad I; Upadhyay G; Singh D; Patel DK; Singh C; Prakash O; Singh MP
    Free Radic Res; 2010 Dec; 44(12):1416-24. PubMed ID: 20815782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial activation is inhibited by corticosterone in dopaminergic neurodegeneration.
    Sugama S; Takenouchi T; Kitani H; Fujita M; Hashimoto M
    J Neuroimmunol; 2009 Mar; 208(1-2):104-14. PubMed ID: 19201037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression.
    Song DY; Yang YC; Shin DH; Sugama S; Kim YS; Lee BH; Joh TH; Cho BP
    Exp Neurol; 2008 Jan; 209(1):268-78. PubMed ID: 18036593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
    Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
    FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
    Liu J; Wang MW; Gu P; Ma QY; Wang YY; Geng Y; Yuan ZY; Cui DS; Zhang ZX; Ma L; Zhang BH; Zhou MG; Zhu AP
    Brain Res; 2010 Jul; 1345():213-20. PubMed ID: 20546706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.